Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
biopharma-reporter
12h
Pricing and logistics: The challenges of getting mpox vaccines to the front line
Although vaccines already exist to prevent mpox, high prices and the risk of side effects make it difficult to roll them out ...
biopharma-reporter
15h
Novartis’ Kisqali receives FDA approval to reduce the risk of breast cancer recurrence
Novartis announced this week that the FDA has approved ribociclib (marketed as Kisqali) for the treatment of people with ...
biopharma-reporter
18h
Cellevate bags €3.2 million to smash viral vector manufacturing bottleneck
The Swedish biotech company Cellevate has raised €3.2 million in a seed round to fuel the commercialization of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Kentucky judge fatally shot
Makes MLB history
COVID, Wuhan market link
Rally attendees injured
Ban called for in TX schools
To get a second moon
To receive Holbrooke award
NYC subway joyride arrest
Gun case sentencing delay
30 yrs in prison for assault
Man charged for threats
EU warns Apple
FTC on privacy controls
US healthcare system falls
AC mayor, wife indicted
UN backs Palestine
Toy Hall of Fame finalists
Retaliated against scientists
New SEC stock pricing rule
Hails economic progress
Deal to build new arena
Brazil threatens daily fines
160M euros to Ukraine
Los Angeles dengue cases
Israel strikes Hezbollah
Launches AI assistant
Existing home sales drop
Cancer deaths decline
US jobless claims fall
Dow, S&P hit record highs
Sets new WNBA record
Feedback